| Literature DB >> 21892347 |
Chia-Ying Kao1,2, Jui-Hsin Su1,2,3, Mei-Chin Lu1,2, Tsong-Long Hwang4, Wei-Hsien Wang2,3,5, Jih-Jung Chen6, Jyh-Horng Sheu3,5, Yueh-Hsiung Kuo7, Ching-Feng Weng8, Lee-Shing Fang9, Zhi-Hong Wen3,5, Ping-Jyun Sung1,2,3,5,8.
Abstract
Five new cembrane-type diterpenoids, lobocrassins A-E (1-5), were isolated from the soft coral Lobophytum crassum. The structures of cembranes 1-5 were established by spectroscopic and chemical methods and by comparison of the spectral data with those of known cembrane analogues. Lobocrassin A (1) is the first cembranoid possessing an α-chloromethyl-α-hydroxy-γ-lactone functionality and is the first chlorinated cembranoid from soft corals belonging to the genus Lobophytum. Lobocrassins B (2) and C (3) were found to be the stereoisomers of the known cembranes, 14-deoxycrassin (6) and pseudoplexaurol (7), respectively. Lobocrassin B (2) exhibited modest cytotoxicity toward K562, CCRF-CEM, Molt4, and HepG2 tumor cells and displayed significant inhibitory effects on the generation of superoxide anion and the release of elastase by human neutrophils.Entities:
Keywords: Lobophytum crassum; cembrane; cytotoxicity; elastase; lobocrassin; superoxide anion
Mesh:
Substances:
Year: 2011 PMID: 21892347 PMCID: PMC3164375 DOI: 10.3390/md9081319
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 6.085
Figure 1.The structures of lobocrassins A–E (1–5), 14-deoxycrassin (6), and pseudoplexaurol (7).
1H and 13C NMR, 1H–1H COSY, and HMBC correlations for cembranoid 1.
| 1 | 2.76 ddd (10.0, 5.2, 4.0) | 44.4 | (CH) | H2-2, H-14 | C-2, C-13, C-14, C-16 |
| 2a | 2.14 ddd (15.6, 5.2, 4.4) | 23.5 | (CH2) | H-1, H-2b, H-3 | C-1, C-3, C-4, C-14, C-15 |
| b | 1.68 ddd (15.6, 8.4, 4.0) | H-1, H-2a, H-3 | C-1, C-3, C-4, C-14 | ||
| 3 | 2.86 dd (8.4, 4.4) | 60.3 | (CH) | H2-2 | C-2 |
| 4 | 64.0 | (C) | |||
| 5a | 2.07 m | 38.0 | (CH2) | H-5b, H2-6 | C-3, C-4, C-7 |
| b | 1.29 m | H-5a, H2-6 | C-3 | ||
| 6a | 2.24 m | 23.4 | (CH2) | H2-5, H-6b, H-7 | C-4, C-7, C-8 |
| b | 2.09 m | H2-5, H-6a, H-7 | C-7, C-8 | ||
| 7 | 5.07 dd (6.4, 6.4) | 122.5 | (CH) | H2-6, H3-19 | C-6, C-9, C-19 |
| 8 | 135.2 | (C) | |||
| 9a | 2.26 m | 38.8 | (CH2) | H-9b, H2-10 | C-7, C-8, C-10, C-11, C-19 |
| b | 2.04 m | H-9a, H2-10 | C-7, C-8, C-10, C-11, C-19 | ||
| 10a | 2.32 m | 24.8 | (CH2) | H2-9, H-10b, H-11 | C-8, C-9, C-11, C-12 |
| b | 2.21 m | H2-9, H-10a, H-11 | C-8, C-9, C-11, C-12 | ||
| 11 | 5.23 dd (6.4, 6.4) | 130.2 | (CH) | H2-10, H3-20 | C-9, C-10, C-20 |
| 12 | 130.1 | (C) | |||
| 13a | 2.67 br d (14.4) | 43.0 | (CH2) | H-13b, H-14 | C-1, C-11, C-12, C-14 |
| b | 2.52 dd (14.4, 7.2) | H-13a, H-14 | C-1, C-11, C-12, C-14 | ||
| 14 | 4.66 ddd (10.0, 7.2, 2.8) | 80.0 | (CH) | H-1, H2-13 | C-12 |
| 15 | 77.2 | (C) | |||
| 16a | 3.79 d (11.6) | 44.5 | (CH2) | H-16b | C-1, C-15, C-17 |
| b | 3.53 d (11.6) | H-16a | C-1, C-15, C-17 | ||
| 17 | 173.4 | (C) | |||
| 18 | 1.34 s | 17.0 | (CH3) | C-3, C-4, C-5 | |
| 19 | 1.60 s | 15.7 | (CH3) | H-7 | C-7, C-8, C-9 |
| 20 | 1.74 s | 17.4 | (CH3) | H-11 | C-11, C-12, C-13 |
| OH-15 | 4.03 br s | C-1, C-15, C-16, C-17 | |||
Spectra were measured at 400 MHz in CDCl3 at 25 °C;
Spectra were measured at 100 MHz in CDCl3 at 25 °C;
J values (in hertz) are in parentheses;
Multiplicity was deduced by DEPT and HMQC experiments and indicated by the usual symbols.
Figure 2.Computer-generated model for 1 using MM2 force field calculations and key NOESY correlations.
1H and 13C NMR data, 1H–1H COSY, and HMBC correlations for cembranoid 2.
| 1 | 2.70 m | 35.5 | (CH) | H2-2, H-14 | C-15, C-16, C-17 |
| 2 | 1.98 m | 25.2 | (CH2) | H-1, H-3 | C-1, C-3, C-4, C-14, C-15 |
| 3 | 4.29 dd (8.0, 5.5) | 79.9 | (CH) | H2-2 | C-1, C-4, C-5, C-18 |
| 4 | 74.6 | (C) | |||
| 5a | 1.87 m | 37.4 | (CH2) | H-5b, H2-6 | C-3, C-4, C-6, C-7, C-18 |
| b | 1.68 ddd (14.5, 9.5, 4.5) | H-5a, H2-6 | C-3, C-4, C-6, C-7, C-18 | ||
| 6a | 2.22 m | 22.4 | (CH2) | H2-5, H-6b, H-7 | C-4, C-5, C-7, C-8 |
| b | 2.16 m | H2-5, H-6a, H-7 | C-4, C-5, C-7, C-8 | ||
| 7 | 5.21 dd (7.0, 7.0) | 125.6 | (CH) | H2-6, H3-19 | C-5, C-6, C-9, C-19 |
| 8 | 135.7 | (C) | |||
| 9 | 2.14 m | 38.8 | (CH2) | H2-10 | C-7, C-8, C-10 |
| 10a | 2.22 m | 24.2 | (CH2) | H2-9, H-10b, H-11 | C-8, C-11, C-12 |
| b | 2.15 m | H2-9, H-10a, H-11 | C-8, C-9, C-11, C-12 | ||
| 11 | 5.01 dd (6.5, 6.5) | 124.7 | (CH) | H2-10 | C-10, C-13, C-20 |
| 12 | 135.3 | (C) | |||
| 13a | 2.21 m | 36.1 | (CH2) | H-13b, H2-14 | C-14 |
| b | 2.02 m | H-13a, H2-14 | C-1, C-11, C-12, C-14, C-20 | ||
| 14a | 1.38 m | 31.5 | (CH2) | H-1, H2-13, H-14b | C-1, C-2, C-12 |
| b | 1.90 m | H-1, H2-13, H-14a | C-12 | ||
| 15 | 140.2 | (C) | |||
| 16 | 166.5 | (C) | |||
| 17a | 6.34 s | 125.7 | (CH2) | H-17b | C-1, C-15, C-16 |
| b | 5.55 s | H-17a | C-1, C-16 | ||
| 18 | 1.27 s | 24.2 | (CH3) | C-3, C-4, C-5 | |
| 19 | 1.56 s | 15.3 | (CH3) | H-7 | C-7, C-8, C-9 |
| 20 | 1.61 s | 15.6 | (CH3) | C-11, C-12, C-13 | |
| OH-4 | 1.89 s | C-3, C-4, C-5, C-18 | |||
Spectra were measured at 500 MHz in CDCl3 at 25 °C;
Spectra were measured at 125 MHz in CDCl3 at 25 °C;
J values (in hertz) are in parentheses;
Multiplicity was deduced by DEPT and HMQC experiments and indicated by the usual symbols.
1H and 13C NMR data, 1H–1H COSY, and HMBC correlations for cembranoid 5.
| 1 | 2.05 m | 39.3 | (CH) | H2-2, H-14 | n.o. |
| 2a | 1.89 ddd (14.5, 5.0, 4.0) | 33.9 | (CH2) | H-1, H-2b, H-3 | C-1, C-3, C-4, C-14, C-15 |
| b | 1.46 ddd (14.5, 10.5, 3.5) | H-1, H-2a, H-3 | C-1, C-3, C-4, C-14, C-15 | ||
| 3 | 2.85 dd (10.5, 4.0) | 62.8 | (CH) | H2-2 | C-2, C-5 |
| 4 | 61.0 | (C) | |||
| 5a | 2.03 m | 38.0 | (CH2) | H-5b, H2-6 | C-3, C-4, C-6, C-7 |
| b | 1.35 m | H-5a, H2-6 | C-6, C-7 | ||
| 6a | 1.99 m | 23.1 | (CH2) | H2-5, H-6b, H-7 | C-4, C-7 |
| b | 2.17 m | H2-5, H-6a, H-7 | C-7 | ||
| 7 | 5.11 dd (6.5, 6.5) | 125.2 | (CH) | H2-6, H3-19 | C-6, C-9, C-19 |
| 8 | 134.6 | (C) | |||
| 9 | 2.25 m | 39.6 | (CH2) | H2-10 | C-8, C-11 |
| 10a | 2.23 m | 24.4 | (CH2) | H2-9, H-10b, H-11 | C-9, C-12 |
| b | 2.21 m | H2-9, H-10a, H-11 | C-9, C-12 | ||
| 11 | 5.39 dd (7.0, 7.0) | 128.7 | (CH) | H2-10, H3-20 | C-10, C-13, C-20 |
| 12 | 136.1 | (C) | |||
| 13 | 4.19 m | 76.6 | (CH) | H2-14 | n.o. |
| 14 | 1.72 m | 40.3 | (CH2) | H-1, H-13 | C-1, C-2, C-12, C-13, C-15 |
| 15 | 150.1 | (C) | |||
| 16 | 1.71 s | 18.8 | (CH3) | H2-17 | C-1, C-15, C-17 |
| 17a | 4.68 s | 109.8 | (CH2) | H3-16, H-17b | C-1, C-16 |
| b | 4.65 s | H3-16, H-17a | C-1, C-16 | ||
| 18 | 1.20 s | 17.6 | (CH3) | C-3, C-4, C-5 | |
| 19 | 1.62 s | 15.3 | (CH3) | H-7 | C-7, C-8, C-9 |
| 20 | 1.62 s | 10.5 | (CH3) | H-11 | C-11, C-12, C-13 |
Spectra were measured at 500 MHz in CDCl3 at 25 °C;
Spectra were measured at 125 MHz in CDCl3 at 25 °C;
J values (in hertz) are in parentheses;
Multiplicity was deduced by DEPT and HMQC experiments and indicated by the usual symbols;
n.o. = not observed.
Cytotoxicity of cembranes 1–4.
| 15.39 | 5.33 | 11.86 | 32.16 | 26.13 | |
| 2.97 | 0.48 | 0.34 | 3.44 | 8.17 | |
| >40 | 11.55 | 9.51 | >40 | 39.77 | |
| 24.00 | 10.53 | 10.99 | 34.91 | >40 | |
| Doxorubicin | 0.24 | 0.05 | 0.07 | 0.71 | 0.46 |
Doxorubicin was used as a reference compound. The results are expressed as mean ± S.D.
Inhibitory effects of cembranes 1–5 on the generation of superoxide anion and the release of elastase by human neutrophils in response to formyl-Met-Leu-Phe/cytochalasin B (FMLP/CB).
| (2.8 ± 1.9) | (0.9 ± 2.5) | |
| 4.8 ± 0.7 | 4.9 ± 0.4 | |
| (1.4 ± 2.4) | (9.6 ± 9.4) | |
| (−1.9 ± 7.3) | (11.0 ± 3.9) | |
| (−1.2 ± 1.5) | (−4.4 ± 9.5) | |
| DPI | 0.8 ± 0.2 | |
| Elastatinal | 30.8 ± 5.7 |
Percentage of inhibition (Inh %) at a concentration 10 μg/mL;
DPI (diphenylene indoniumn) and elastatinal were used as reference compounds. Results are expressed as mean ± S.E.M., and comparisons were made using Student’s t-test. A probability of ≤ 0.05 was considered significant.